HEALTHCARE

July 9, 2020

New Index: A Young Population Has Been Africa’s Best Defense Against COVID-19 Deaths So Far, But Several Regions Are Dangerously Vulnerable

A new index designed to fill a critical information gap and help African governments, health officials, non-governmental organizations, and others respond to the coronavirus pandemic finds that although Africa has not yet been overwhelmed by COVID-19, several regions are showing troubling"...

Read More >>

July 9, 2020

New AMR Action Fund Steps in to Save Collapsing Antibiotic Pipeline With Pharmaceutical Industry Investment of US$1 Billion

Today, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund [www.AMRactionfund.com], a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR. The companies have raised so far nearly US$1 billion new funding to support clinical research of innovative new antibiotics that are addressing the most resistant bacteria and......

Read More >>

July 8, 2020

Takeda and the New York Academy of Sciences Announce 2020 Innovators in Science Award Winners

Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) and the New York Academy of Sciences announced today the Winners of the third annual Innovators in Science Award for their excellence in and commitment to innovative science that has significantly advanced the field of rare disease research. Each Winner receives a prize of US $200,000. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200708005039/en/ The 2020 Winner of the Senior Scientist Award is Adrian R. Krainer, Ph.D., St. Giles Foundation Professor at Cold Spring Harbor Laboratory. Prof. Krainer is......

Read More >>

July 7, 2020

Marie Stopes Nigeria Donates Items to Lagos

Marie Stopes International Organisation Nigeria (MSION) has donated maternal health medications, Misoclear, its brand of socially marketed misoprostol used in the management of postpartum hemorrhage in women after childbirth, to the Lagos state government.

The"...

Read More >>

July 7, 2020

Health Ministry sends coronavirus aid to Sabha

The Ministry of Health has sent medical supplies to the city of Sabha as part of the efforts to contain the spread of coronavirus.

The shipment consisting of medical supplies needed to fight Covid-19 is the second"...

Read More >>

July 7, 2020

Turkey sends another batch of medical supplies to Libya

A Turkish air ambulance aircraft carrying medical supplies needed to tackle the coronavirus pandemic arrived at Matiga International Airport on Saturday evening.

The plane departed from Istanbul and was basically"...

Read More >>

July 7, 2020

Dubai achieves another milestone in healthcare with the launch of state-of-the-art cosmetic surgery hospital

NMC Healthcare has officially launched its new CosmeSurge Hospital in Jumeirah. The facility, completed in December of last year, specialises in providing cosmetic surgeries, and is located near the iconic Burj Al Arab. This will be the 17th branch of the CosmeSurge brand of facilities.

"...

Read More >>

July 7, 2020

rf IDEAS® Adds HID® Mobile Access to Its WAVE ID® Mobile Offering

rf IDEAS, a leading manufacturer of credential readers for logical access and authentication, continues to advance the future of secure mobile access. Developed in partnership with HID Global, the newest addition to the rf IDEAS WAVE ID Mobile reader line supports the HID Mobile Access"...

Read More >>

July 5, 2020

NOC donates testing devices to Al-Thawra Hospital of Al-Bayda

The Sustainable Development Department of the National Oil Corporation (NOC) on Thursday, donated a testing PCR device with 5,000 test strips, in addition to temperature measuring devices to the Al-Thawra Central Teaching Hospital in Al-Bayda, in response to the Coronavirus crisis.

"...

Read More >>

July 4, 2020

EUSA Pharma Announces FDA Approval of Phase 3 Clinical Trial for Siltuximab in Hospitalized Patients With COVID-19 Associated Acute Respiratory Distress Syndrome

EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today announced that the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled Phase 3 clinical trial protocol to evaluate the safety and efficacy of intravenous"...

Read More >>

Found articles: - Pages